A rapid test, developed by an ASU professor working with Mayo Clinic, could be available for use by the end of the year.Continue reading
Author Archive: AZBio
As Congress Focuses on the Budget – Life Science Leaders Focus on an EPIC solution.
From full page ads in the Boston Globe to panels of thought leaders at BIO 2025,and podcasts, leaders are highlighting the problems being created by the Pill Penalty that is part of the Inflation Reduction Act. As Congress works through the Budget Reconciliation Process, the EPIC Act could be a solution.Continue reading
Peter Pellerito, Senior Policy Advisor with Biotechnology Innovation Organization, Honored with AURP Vision Award
Tucson, AZ, and College Park, MD, June 20, 2025 – The Association of University Research Parks (AURP) this week presented the AURP Vision Award to Peter Pellerito, Senior Policy Advisor at the Biotechnology Innovation Organization (BIO), during the AURP BIO Health Caucus (held in advance of the BIO 2025 International Convention in Boston).Continue reading
Caris Life Sciences Completes Initial Public Offering (IPO)
Reuters reports that Caris Life Sciences raised $494.1 million in its Nasdaq initial public offering
Life Sciences Workforce Collaborative (LSWC) Officially Launches to Strengthen Talent Pipelines Across the U.S.
Formerly the Coalition of State Bioscience Institutes (CSBI), LSWC to drive national coordination and visibility for life sciences workforce development
Wexford Science & Technology Launches Pre-Leasing for 800 PBC
Builds on Momentum of PBC, ASU Health With 850 PBC Nearing Full CapacityContinue reading
FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests
The U.S. Food and Drug Administration today announced its Commissioner’s National Priority Voucher (CNPV) program to enhance the health interests of Americans. The new voucher may be redeemed by drug developers to participate in a novel priority program by the FDA that shortens its review time from approximately 10-12 months to 1-2 months following a sponsor’s final drug application submission.Continue reading
Global Impact of Phoenix Bioscience Core and TGen Featured in New BBC Content Series
BOSTON – The Translational Genomics Research Institute (TGen), part of City of Hope, took part in a new global content series presented by the Biotechnology Innovation Organization (BIO) and produced by BBC StoryWorks Commercial Productions. TGen is a leading biomedical research organization based in the Phoenix Bioscience Core (PBC).
Smart sensors and smarter health: How AI and wearables are reimagining preventive health care
University of Arizona Health Sciences researchers are harnessing artificial intelligence and wearable tech to forecast labor, detect stress and transform how we monitor our health – before symptoms appear.Continue reading